Paul Farrow of Oxford PharmaGenesis reviews the published evidence that supports the new AMWA-EMWA-ISMPP joint position statement on the role of professional medical writers.
This is the first unified position statement on the role of professional medical writers from three leading professional organizations:
American Medical Writers Association (AMWA) – see http://www.amwa.org/position_statement
European Medical Writers Association (EMWA) – see http://journal.emwa.org/writing-better/amwa-emwa-ismpp-joint-position-statement-on-the-role-of-professional-medical-writers/
International Society for Medical Publication Professionals (ISMPP) – see http://www.ismpp.org/advocacy
The Joint Position Statement describes, for the first time, a global standard for professional medical writers and replaces previous position statements and guidelines from these participating organizations
Recorded 5 April 2017 at a MedComms Networking event in Oxford. Produced by NetworkPharma.tv
We are building a library of free webcasts, like this one, for the global MedComms Community and others at http://www.networkpharma.tv and we’d welcome your suggestions for new topics and speakers.
Full details of this MedComms Networking event are at http://medcommsnetworking.com/event87.html
Paul’s presentation (PDF format) is at http://medcommsnetworking.com/presentations/farrow_050417.pdf
Paul’s Linkedin page is at https://www.linkedin.com/in/pauljfarrow/
More about Oxford PharmaGenesis can be found at http://www.pharmagenesis.com
Filming and technical direction by Mario Crispino, Freelance Cameraman & Editor
[For the avoidance of doubt: this video is intended to be freely accessible to all. Please feel free to share and use however you like. Cheers, Peter Llewellyn, Director NetworkPharma Ltd and Founder of the MedComms Networking Community activity at http://www.medcommsnetworking.com]